Advertisement
Canada markets closed
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7286
    -0.0002 (-0.02%)
     
  • CRUDE OIL

    79.23
    +0.24 (+0.30%)
     
  • Bitcoin CAD

    83,930.90
    -1,780.12 (-2.08%)
     
  • CMC Crypto 200

    1,302.08
    +7.41 (+0.57%)
     
  • GOLD FUTURES

    2,316.40
    -5.90 (-0.25%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,166.25
    -20.25 (-0.11%)
     
  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • CAD/EUR

    0.6776
    0.0000 (0.00%)
     

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Most investors are comfortable with the idea of businesses like Apple and Microsoft having market caps in excess of $1 trillion. Today, Eli Lilly's market cap is a little north of $410 billion, which puts it among the top handful of big pharma companies. Its trailing 12-month net income is $6.2 billion, and its trailing price-to-earnings ratio is near 69, which is fairly high, but not at bloated tech stock levels.